Viewing Study NCT04105335


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-02-02 @ 10:44 AM
Study NCT ID: NCT04105335
Status: COMPLETED
Last Update Posted: 2025-03-06
First Post: 2019-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)
Sponsor: Mina Alpha Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oligonucleotide View
None saRNA View
None Pembrolizumab View
None Tumour microenvironment View
None Myeloid-derived suppressor cells View
None C/EBP-a View
None CEBPA View